US 8802709
Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
granted A61KA61K31/4164A61K45/06
Quick answer
US patent 8802709 (Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4164, A61K45/06, A61P, A61P43/00